FBIOX vs. IBB
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and iShares Nasdaq Biotechnology ETF (IBB).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBIOX or IBB.
Key characteristics
| FBIOX | IBB | |
|---|---|---|
| YTD Return | 19.92% | 6.51% |
| 1Y Return | 48.95% | 25.48% |
| 3Y Return (Ann) | -0.56% | -1.86% |
| 5Y Return (Ann) | 1.14% | 5.92% |
| 10Y Return (Ann) | 1.38% | 4.39% |
| Sharpe Ratio | 2.37 | 1.48 |
| Sortino Ratio | 3.22 | 2.14 |
| Omega Ratio | 1.38 | 1.25 |
| Calmar Ratio | 0.96 | 0.74 |
| Martin Ratio | 10.45 | 6.88 |
| Ulcer Index | 4.72% | 3.69% |
| Daily Std Dev | 20.82% | 17.17% |
| Max Drawdown | -71.96% | -62.85% |
| Current Drawdown | -27.55% | -17.30% |
Correlation
The correlation between FBIOX and IBB is 0.94, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FBIOX vs. IBB - Performance Comparison
In the year-to-date period, FBIOX achieves a 19.92% return, which is significantly higher than IBB's 6.51% return. Over the past 10 years, FBIOX has underperformed IBB with an annualized return of 1.38%, while IBB has yielded a comparatively higher 4.39% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. IBB - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
FBIOX vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBIOX vs. IBB - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 0.67%, more than IBB's 0.31% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 0.67% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% | 0.25% |
IBB iShares Nasdaq Biotechnology ETF | 0.31% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
FBIOX vs. IBB - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.96%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for FBIOX and IBB. For additional features, visit the drawdowns tool.
Volatility
FBIOX vs. IBB - Volatility Comparison
Fidelity Select Biotechnology Portfolio (FBIOX) has a higher volatility of 5.68% compared to iShares Nasdaq Biotechnology ETF (IBB) at 4.66%. This indicates that FBIOX's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.